ReoPro

InfoI

New member
<h1>ReoPro </h1><p>ReoPro (abciximab) is indicated as an adjunct to PCI for the prevention of cardiac ischemic complications:

* In patients undergoing PCI
* In patients with UA not responding to conventional medical therapy when PCI is planned within 24 hours

Safety and efficacy of ReoPro use in patients not undergoing PCI have not been established. ReoPro is intended for use with aspirin and heparin and has been studied only in that setting, as described in clinical studies.</p>
 
Back
Top